Published: Guidance, quality standards and advice
Showing 11 to 17 of 17
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Nivolumab for previously treated advanced renal cell carcinoma | TA417 | ||
| Dapagliflozin in triple therapy for treating type 2 diabetes | TA418 | ||
| Apremilast for treating moderate to severe plaque psoriasis | TA419 | ||
| Dapagliflozin in combination therapy for treating type 2 diabetes | TA288 | ||
| High-throughput non-invasive prenatal testing for fetal RHD genotype | HTG420 | ||
| Minimal change disease and focal segmental glomerulosclerosis in adults: rituximab | ES1 | ||
| Physical health of people in prison | NG57 |